Tactile Systems Technology, Inc. ( TCMD ) NASDAQ Global Market

Cena: 27.8 ( 3.69% )

Aktualizacja 12-05 21:53
NASDAQ Global Market
Branża: Medycyna - Urządzenia

Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna

symbol 1D 5D 1M 3M 6M YTD 1Y 3Y 5Y 10Y
TCMD 1.7 1.9 20.9 99.8 164.4 56.6 41.0 166.8 -36.6 142.0
Notowania:

Opis firmy:

Tactile Systems Technology, Inc., firma zajmująca się technologią medyczną, angażuje się w rozwój i zapewnienie urządzeń medycznych w chorobach przewlekłych w Stanach Zjednoczonych. Firma oferuje system FlexiTouch Plus, pneumatyczne urządzenie kompresyjne do leczenia obrzęku limfatycznego; Układ przedsiębiorstwa, przenośne urządzenie kompresyjne pneumatyczne, które jest stosowane do leczenia zaburzeń żylnych, takich jak obrzęk limfatyczny i przewlekła niewydolność żylna, w tym wrzody nóg żylnych; i Afflovest, przenośny test oscylacji ściany klatki piersiowej o wysokiej częstotliwości do leczenia zachowanych wydzieliny płuc, takich jak oskrzeli, mukowiscydoza i różne zaburzenia nerwowo -mięśniowe. Firma została zarejestrowana w 1995 roku i ma siedzibę w Minneapolis w stanie Minnesota.

Informacje o spółce:
Sektor: Zdrowie
Branża: Medycyna - Urządzenia
Zatrudnienie: 992
Giełda: NASDAQ Global Market
Ilość akcji w obrocie: 98.1864
Ilość akcji: Brak danych
Debiut giełdowy: 2016-07-28
WWW: https://www.tactilemedical.com
CEO: Ms. Sheri Louise Dodd
Adres: 3701 Wayzata Boulevard
Siedziba: 55416 Minneapolis
ISIN: US87357P1003
Wskaźniki finansowe
Kapitalizacja (USD) 620 929 180
Aktywa: 297 924 000
Cena: 27.8
Wskaźnik Altman Z-Score: 6.41
Stabilny (niskie ryzyko bankructwa)
Dywidenda: 0
P/E: 36.6
Ilość akcji w obrocie: 98%
Średni wolumen: 368 047
Ilość akcji 22 335 582
Wskaźniki finansowe
Przychody TTM 298 851 000
Zobowiązania: 81 327 000
Przedział 52 tyg.: 8.61 - 28.0437
Piotroski F-Score:
EPS: 0.8
P/E branży: 31.0
Beta: 1.173
Raport okresowy: 2026-02-17
WWW: https://www.tactilemedical.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Ms. Sheri Louise Dodd Chief Executive Officer & Director 64 375 1966
Ms. Elaine M. Birkemeyer Chief Financial Officer 590 960 0
Ms. Kristie T. Burns Senior Vice President of Marketing & Clinical Affairs 587 020 1972
Ms. Sherri Ferstler Senior Vice President of Sales 431 996 0
Mr. Daniel L. Reuvers Advisor 1 364 600 1963
Mr. Jerry A. Sauber Senior Vice President of Manufacturing, Operations, R&D 0 0
Janelle M. Strop Chief Human Resource Officer 0 0
Mr. John David Kaercher Chief Information Officer 0 0
Ms. Sunday J. Hoy Esq. Vice President of Regulatory Affairs & Chief Compliance Officer 0 0
Dr. Antonios P. Gasparis F.A.C.S., M.D. Chief Medical Officer & Member of Vascular Strategic Advisory Board 0 0
Lista ETF z ekspozycją na akcje Tactile Systems Technology, Inc.
Symbol ETF Ilość akcji Wartość
VTS.AX 699 135 10 535 964
VTI 699 135 10 535 964
IWM 559 343 14 375 115
XSU.TO 559 343 137 752
DBXW.DE 506 622 11 308 037
XWEH.DE 506 622 11 308 037
XMWD.L 506 622 13 020 193
VXF 239 974 3 616 408
IWN 195 205 5 016 768
DFAT 149 396 3 575 046
AVUV 125 981 3 014 725
VTWO 111 310 1 677 441
HTEC 70 260 0
DFSV 69 978 1 674 573
DFAS 64 045 1 532 596
FESM 63 017 800 315
IWC 55 239 1 419 642
AVSC 48 040 1 149 597
DFAC 40 780 975 865
PSC 39 695 949 901
VFMF 37 953 525 269
VFVA 36 841 509 879
R2SC.L 36 060 658 913
R2US.L 36 060 862 915
ZPRR.DE 36 060 749 097
PRFZ 32 409 832 911
VFQY 30 796 426 216
SFLO 30 061 772 567
VVL.TO 27 525 530 048
VVLU.AX 27 356 571 267
GSSC 25 293 256 218
SVAL 18 356 471 749
VTWV 15 098 227 526
EES 14 004 359 902
XRSG.L 13 894 27 276 891
XRS2.DE 13 894 310 126
XRSU.L 13 894 357 083
ROSC 12 164 291 084
RSSL 10 712 248 411
AFSM 10 010 287 171
IWV 7 488 192 441
OMFS 6 857 176 224
DFUS 5 496 131 519
QQQS 4 047 104 007
DFAU 3 983 95 313
SQLV 3 931 94 068
FLQS 2 496 64 147
BUYO 2 370 56 714
VTHR 2 034 30 652
URTY 1 959 50 346
UWM 1 578 40 554
AVUS 1 520 36 373
DCOR 1 174 28 093
DXUV 36 861
HDG 30 771
PZW.TO 0 4 556
SC0K.DE 0 0
RTYS.L 0 0
Wiadomości dla Tactile Systems Technology, Inc.
Tytuł Treść Źródło Aktualizacja Link
Tactile Systems Stock Tumbles As Q1 Earnings Fall Short Of Expectations Tactile Systems Technology, Inc. TCMD traded lower on Tuesday after the company's Q1 earnings missed Wall Street expectations on Monday. benzinga.com 2025-05-06 20:54:16 Czytaj oryginał (ang.)
Tactile Systems Technology, Inc. (TCMD) Q1 2025 Earnings Call Transcript Tactile Systems Technology, Inc. (NASDAQ:TCMD ) Q1 2025 Earnings Conference Call May 5, 2025 5:00 PM ET Company Participants Sam Bentzinger - Investor Relations, Gilmartin Group LLC Sheri Dodd - Chief Executive Officer Elaine Birkemeyer - Chief Financial Officer Conference Call Participants Margaret Kaczor Andrew - William Blair Ryan Zimmerman - BTIG Anderson Schock - B. Riley Securities Operator Welcome, ladies and gentlemen, to the First Quarter 2025 Earnings Conference Call for Tactile Medical. seekingalpha.com 2025-05-06 03:00:20 Czytaj oryginał (ang.)
Tactile Systems Technology (TCMD) Reports Q1 Loss, Lags Revenue Estimates Tactile Systems Technology (TCMD) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.05 per share a year ago. zacks.com 2025-05-05 22:30:36 Czytaj oryginał (ang.)
Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results MINNEAPOLIS, May 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2025. globenewswire.com 2025-05-05 20:05:00 Czytaj oryginał (ang.)
Tactile Medical to Release First Quarter of Fiscal Year 2025 Financial Results on May 5, 2025 MINNEAPOLIS, April 21, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that first quarter of fiscal year 2025 financial results will be released after the market closes on Monday, May 5, 2025. globenewswire.com 2025-04-21 20:05:00 Czytaj oryginał (ang.)
Tactile Medical to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference MINNEAPOLIS, March 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference, which is being virtually held from March 17th – 20th. Management will participate in a virtual presentation on Tuesday, March 18th at 12:00 p.m. Eastern Time. globenewswire.com 2025-03-05 18:05:00 Czytaj oryginał (ang.)
Tactile Systems Technology, Inc. (TCMD) Q4 2024 Earnings Call Transcript Tactile Systems Technology, Inc. (NASDAQ:TCMD ) Q4 2024 Earnings Conference Call February 18, 2025 5:00 PM ET Company Participants Sam Bentzinger - Investor Relations, Gilmartin Group LLC Sheri Dodd - Chief Executive Officer Elaine Birkemeyer - Chief Financial Officer Conference Call Participants Max Smock - William Blair Adam Maeder - Piper Sandler Iseult McMahon - BTIG Kyle Bauser - B. Riley Securities Suraj Kalia - Oppenheimer & Company Operator Please standby. seekingalpha.com 2025-02-19 01:11:07 Czytaj oryginał (ang.)
Tactile Systems Technology (TCMD) Tops Q4 Earnings and Revenue Estimates Tactile Systems Technology (TCMD) came out with quarterly earnings of $0.40 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.38 per share a year ago. zacks.com 2025-02-18 22:20:19 Czytaj oryginał (ang.)
Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results MINNEAPOLIS, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the fourth quarter and full year ended December 31, 2024. globenewswire.com 2025-02-18 18:05:00 Czytaj oryginał (ang.)
Tactile Medical to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 18, 2025 MINNEAPOLIS, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that fourth quarter and fiscal year 2024 financial results will be released after the market closes on Tuesday, February 18, 2025. globenewswire.com 2025-02-05 18:05:00 Czytaj oryginał (ang.)
Tactile Medical Appoints Laura King to Board of Directors MINNEAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Laura King to the Company's Board of Directors (“Board”) and as a member of the Audit and Compliance & Reimbursement Committees, effective January 13, 2025. globenewswire.com 2025-01-13 10:00:00 Czytaj oryginał (ang.)
Is Tactile Systems Technology (TCMD) a Great Value Stock Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2025-01-01 12:51:22 Czytaj oryginał (ang.)
TCMD Stock Rises 20% in Three Months: Should You Buy, Hold or Sell? Tactile Systems' top line reflects strong demand for its existing products. Workflow enhancements are driving efficiency. zacks.com 2024-12-31 11:45:37 Czytaj oryginał (ang.)
Should Value Investors Buy Tactile Systems Technology (TCMD) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2024-12-16 18:36:14 Czytaj oryginał (ang.)
Are Investors Undervaluing Tactile Systems Technology (TCMD) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2024-11-28 12:41:18 Czytaj oryginał (ang.)
Tactile Systems Technology, Inc. (TCMD) Hit a 52 Week High, Can the Run Continue? Tactile Systems Technology (TCMD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. zacks.com 2024-11-26 12:20:31 Czytaj oryginał (ang.)
Tactile Medical to Present at the Piper Sandler 36th Annual Healthcare Conference MINNEAPOLIS, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the Piper Sandler 36th Annual Healthcare Conference, which is being held at the Lotte New York Palace in New York, NY from December 3rd – 5th. Management will participate in a fireside chat on Tuesday, December 3rd at 10:00 a.m. Central Time. globenewswire.com 2024-11-19 18:05:00 Czytaj oryginał (ang.)
Bull Of The Day: Tactile Systems Technology (TCMD) Tactile Systems Technology (TCMD) is a Zacks Rank #2 (Buy) that has an A for Value and a C for Growth.  The company develops medical devices for the treatment of chronic diseases at home. zacks.com 2024-11-18 10:10:18 Czytaj oryginał (ang.)
Is Tactile Systems Technology (TCMD) Stock Undervalued Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2024-11-12 12:45:34 Czytaj oryginał (ang.)
Trump's Win and Rate Cut to Benefit Small Businesses: 5 Top Picks Trump's win and rate cut should benefit small businesses to a good extent. Five small-cap stocks to buy are: PBAM, MAX, TCMD, TZOO, SABK. zacks.com 2024-11-08 17:01:11 Czytaj oryginał (ang.)
Wall Street Analysts Believe Tactile Systems Technology (TCMD) Could Rally 45.9%: Here's is How to Trade The consensus price target hints at a 45.9% upside potential for Tactile Systems Technology (TCMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. zacks.com 2024-11-07 13:00:48 Czytaj oryginał (ang.)
Tactile Systems Technology, Inc. (TCMD) Q3 2024 Earnings Call Transcript Tactile Systems Technology, Inc. (NASDAQ:TCMD ) Q3 2024 Earnings Conference Call November 4, 2024 5:00 PM ET Company Participants Sam Bentzinger - Investor Relations, Gilmartin Group LLC Sheri Dodd - Chief Executive Officer Elaine Birkemeyer - Chief Financial Officer Conference Call Participants Kyle Bauser - B. Riley Operator Please standby. seekingalpha.com 2024-11-04 20:42:29 Czytaj oryginał (ang.)
Tactile Systems Technology (TCMD) Tops Q3 Earnings Estimates Tactile Systems Technology (TCMD) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.85 per share a year ago. zacks.com 2024-11-04 20:31:07 Czytaj oryginał (ang.)
Tactile Systems Technology, Inc. Reports Third Quarter 2024 Financial Results MINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the third quarter ended September 30, 2024 and announced the adoption of a share repurchase program. Third Quarter 2024 Summary & Recent Business Highlights: Total revenue increased 5% year-over-year to $73.1 million Lymphedema product revenue increased 4% over Q3 2023 Airway clearance product revenue increased 10% over Q3 2023 Net income of $5.2 million versus $22.3 million in Q3 2023 Adjusted EBITDA of $10.7 million versus $7.7 million in Q3 2023 Operating cashflow of $24.3 million year-to-date, compared to $17.5 million in the prior year period Ended Q3 2024 with $82.1 million in cash and cash equivalents Launched Nimbl, our next-generation lymphedema therapy platform for upper extremity conditions Announced publication of positive clinical trial results in VA lymphedema patients using Flexitouch therapy Authorized a program to repurchase up to $30.0 million of the Company's common stock “In the third quarter, we delivered solid gross margin expansion, drove continued improvements in profitability, and achieved double-digit growth in both our commercial and VA lymphedema channels,” said Sheri Dodd, President and Chief Executive Officer of Tactile Medical. globenewswire.com 2024-11-04 18:05:00 Czytaj oryginał (ang.)
Tactile Systems Technology (TCMD) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Tactile Systems Technology (TCMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com 2024-10-28 13:05:15 Czytaj oryginał (ang.)
Why Investors Need to Take Advantage of These 2 Medical Stocks Now Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP. zacks.com 2024-10-25 13:51:16 Czytaj oryginał (ang.)
Tactile Medical to Release Third Quarter of Fiscal Year 2024 Financial Results on November 4, 2024 MINNEAPOLIS, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that third quarter of fiscal year 2024 financial results will be released after the market closes on Monday, November 4, 2024. globenewswire.com 2024-10-21 20:05:00 Czytaj oryginał (ang.)
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP. zacks.com 2024-10-15 13:51:14 Czytaj oryginał (ang.)
The Future of Medical Devices: Two Strong Buys You Can't Miss The medical device market, a powerhouse sector, is projected to exceed $600 billion by 2025. This growth is fueled by a combination of factors, including an aging population, rising healthcare costs, and rapid technological advancements powered by advanced artificial intelligence (AI) and biotechnology. marketbeat.com 2024-10-10 11:00:23 Czytaj oryginał (ang.)
Tactile Medical Launches Next-Generation Nimbl™ Lymphedema Platform Initial Launch Focused on Treating Patients Suffering from Upper Extremity Lymphedema Initial Launch Focused on Treating Patients Suffering from Upper Extremity Lymphedema globenewswire.com 2024-10-02 12:00:00 Czytaj oryginał (ang.)
Tactile Medical Stock Rises After Positive Flexitouch Trial Results TCMD announces a new study evaluating Flexitouch. The study reveals significant improvements in health-related quality of life and clinical outcomes. zacks.com 2024-09-26 16:41:30 Czytaj oryginał (ang.)